SQOR and Leigh syndrome: This discovery offers new insight into treating conditions such as Leigh syndrome (caused by complex I deficiency) or colorectal cancers with CBS overexpression by indirectly modulating SQOR activity via metabolic supplementation (e.g., CoQ10).